InsidersTradesSigma
Browse the detailed record of transactions filed by Charles Ballantyne, 首席财务官. Director active across 2 companies, notably Hansa Biopharma AB. In total, 1 disclosures have been recorded. History available since 7 November 2025. The latest transaction was disclosed on 7 November 2025 (Purchase). Regulator: FIN-FSA. All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Charles Ballantyne is the Chief Financial Officer of Hansa Biopharma AB, a company specializing in the development of biological therapies. As CFO, he is responsible for the financial management and economic strategy of the company. His expertise in the financial field is essential in guiding Hansa Biopharma in its growth initiatives.